Vaginal Dryness and GSM: The Menopause Symptom Nobody Talks About
Genitourinary syndrome of menopause (GSM) is the current term for what used to be called vaginal atrophy — the name changed specifically to capture the fuller symptom picture, which includes urinary symptoms alongside vaginal ones. It's extremely common and, unlike hot flashes, tends to get worse rather than better without treatment.
Last updated August 2026
What's actually happening
Declining estrogen thins and dries the vaginal and urinary tissue, and reduces blood flow and elasticity there. This is a direct, mechanical, hormone-driven tissue change — not a vague consequence of "getting older," but a specific and treatable process.
The full symptom picture, not just dryness
Burning, itching, and pain with sex (dyspareunia) are the vaginal symptoms most people connect to menopause. Urinary urgency, recurrent UTIs, and burning with urination are also part of GSM — but people often don't connect these to the same underlying cause, and treat them as a separate, unrelated problem.
It doesn't go away on its own, and it's progressive
Unlike hot flashes, which often ease over time as the body adjusts, GSM tends to worsen without treatment, since the underlying tissue change doesn't reverse itself spontaneously. This is a genuine reason to treat it rather than wait it out.
Non-hormonal first steps
Vaginal moisturizers, used regularly (not just around sex), and lubricants specifically for sex are different products serving different purposes, and can meaningfully help with milder symptoms on their own.
Local vaginal estrogen — treating the actual cause
Low-dose vaginal estrogen (cream, tablet, or ring) treats the tissue directly with minimal absorption into the rest of the body — which makes it a reasonable option even for people who've chosen not to use, or can't use, systemic hormone therapy, including many breast cancer survivors after discussion with their oncology team. The label carries a black-box warning inherited from systemic estrogen products; current evidence and specialty society guidance don't support that same level of concern for low-dose local vaginal use specifically — worth discussing directly if that warning has made you hesitant.
Other options
Vaginal DHEA (prasterone) is a non-estrogen option that's converted to active hormone locally in the tissue. Oral ospemifene is a non-vaginal pill option for people who prefer not to use a vaginal product at all.
Worth discussing with your provider
Educational information only — general patterns that vary by person. This is not medical advice, a diagnosis, or a substitute for care from your own clinician.
More from Education